Stents to Day Just Don't Have the Thrombotic Risk

With the current generation of stents, we have randomized control evidence from stop dap to show that there's a minimal risk of stenthrombosis in post pc i patients who receive daps for a month followed by clapit monotherapy. Even with just one month of dual antiplate letherapy the rate of stanthrombosis was about zero point one %. The bleeding story is identical up front and then marginally increases over time. Aggressive antiplate litherype has the biggest reduction in aschemic endpoints but long term you continue to get marginal benefit from continuing more aggressive thrombotic regiment.